Skip to content

Pelvic-sacral septum ginger fire therapy in the treatment of thin endometrium with kidney deficiency and blood stasis: a single-center randomized controlled trial

A randomized controlled study of pelvic-sacral septum ginger fire therapy in the treatment of kidney deficiency and blood stasis type thin endometrium

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050959
Enrollment
Unknown
Registered
2021-09-08
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thin endometrium

Interventions

Experimental group:Ginger fire therapy for pelvic and sacral septum
Control group:Oral estradiol valerate

Sponsors

The Third Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18-45 years (including both ends); 2. Normal menstrual cycle, but oligomenorrhea or infertility; 3. No hormone therapy for 3 months before enrollment; 4. No pregnancy plan in the past six months; 5. Patients voluntarily participate in this study and can actively cooperate with the experimental process of the study; 6. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those with obvious uterine adhesions, uterine fibroids and other uterine cavity abnormalities and reproductive tract abnormalities were found in the examination; 2. Combined with serious medical diseases, coagulation disorders and mental system diseases; 3. Patients who cannot tolerate the examination during this study; 4. Those who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Endometrial thickness;

Secondary

MeasureTime frame
Subendometrial blood flow parameters;Estradiol;TCM symptom scale;Menstrual blood loss;

Countries

China

Contacts

Public ContactChen Lifang

The Third Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine

clfang@163.com+86 13957157278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026